We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advice for medical professionals to follow when assessing drivers with diabetes mellitus.
As with any medicine, the MHRA will keep the safety and effectiveness of teplizumab under close review.
You may need to tell DVLA if you have diabetes, depending on the treatment you're getting
A Randomised Controlled Trial in a Nigerian Tertiary Care Hospital
Guidance on the safe and effective use of GLP-1 medicines for weight loss and diabetes.
Information explaining diabetic retinopathy, a disease screened for by the NHS diabetic eye screening (DES) programme.
Information for people referred from diabetic eye screening (DES) because they need regular monitoring or treatment.
Training and continuing professional development (CPD) for people working in the diabetic eye screening (DES) programme in England.
This study reported high prevalence, especially of undiagnosed cases amongst adults, most have uncontrolled blood sugar levels
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).